Funding for this research was provided by:
University of Sydney (n.a.)
Western Sydney University (na)
Received: 26 August 2019
Accepted: 3 September 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: Adult participants provided verbal rather than written informed consent, due to the practicalities of carrying out a large-scale survey and the low risk nature of the survey content. For minors (15–17 year olds) enrolled in the study, written consent was obtained from the participant’s parent/guardian. The surveys and method of obtaining consent were approved by the University of Adelaide Human Ethics Committee H-097-2010.
: Not applicable.
: AB declares no competing interests. HM declares no competing interests. ST is the Chair of the Shire Australasian Binge Eating Disorder Advisory Committee. He has received both research grants and travel grants from Shire and has received consultancy fees for both commissioned reports and speaking engagements. He is also in receipt of royalties from McGraw Hill for contribution to text books. PH receives/has received sessional fees and lecture fees from the Australian Medical Council, Therapeutic Guidelines publication, and New South Wales Institute of Psychiatry and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, and Blackwell Scientific Publications, Biomed Central and PlosMedicine and she has received research grants from the NHMRC and ARC. She is Chair of the National Eating Disorders Collaboration Steering Committee in Australia (2012-) and Member of the ICD-11 Working Group for Eating Disorders (2012–2018) and was Chair Clinical Practice Guidelines Project Working Group (Eating Disorders) of RANZCP (2012–2015). In the past 5 years she has prepared a report under contract for Shire Pharmaceuticals) and received honoraria for education of psychiatrists from Shire Pharmaceuticals (Takeda group). All views in this paper are her own.